bf/NASDAQ:GBT_icon.jpeg

NASDAQ:GBT

Global Blood Therapeutics, Inc.

  • Stock

USD

Last Close

68.48

04/10 20:00

Volume Today

3.28M

Avg: -

PE Ratio

−27.41

PFCF: -

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Select
  • website

    www.gbt.com
  • ipo date

    Aug 12, 2015
  • full time employees

    457
  • currency

    USD

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety an...Show More

Earnings

Earnings per Share (Estimate*)

-5-4-3-2-12014-03-312016-03-292017-08-072019-05-082021-02-242022-11-02

Revenue (Estimate*)

20M40M60M80M2014-03-312016-03-292017-08-072019-05-082021-02-242022-11-02

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.